{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:35:14Z","timestamp":1793662514266,"version":"4.5.1"},"reference-count":60,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,26]]},"abstract":"<jats:p>Currently, we have insufficient understanding of venous thromboembolism in cancer patients. In this article, the authors reveal a novel mechanism for colon cancer-associated venous thrombosis using a murine model.<\/jats:p>","DOI":"10.1182\/blood.2019001675","type":"journal-article","created":{"date-parts":[[2019,11,5]],"date-time":"2019-11-05T16:43:21Z","timestamp":1572972201000},"page":"2399-2413","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":48,"title":["Metabolites in a mouse cancer model enhance venous thrombogenicity through the aryl hydrocarbon receptor\u2013tissue factor axis"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2097-6882","authenticated-orcid":false,"given":"Mostafa","family":"Belghasem","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Roth","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Richards","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1879-7567","authenticated-orcid":false,"given":"Marc Arthur","family":"Napolene","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkiruka","family":"Arinze","sequence":"additional","affiliation":[{"name":"Department of Surgery, Boston University Medical Center, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chimera","family":"Lyle","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Spencer","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M.","family":"Francis","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristal","family":"Thompson","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"},{"name":"Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Andry","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5439-6501","authenticated-orcid":false,"given":"Stephen A.","family":"Whelan","sequence":"additional","affiliation":[{"name":"Chemical Instrumentation Center, Boston University, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman","family":"Lee","sequence":"additional","affiliation":[{"name":"Chemical Instrumentation Center, Boston University, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katya","family":"Ravid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"},{"name":"Whitaker Cardiovascular Institute, Boston University School of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6663-6058","authenticated-orcid":false,"given":"Vipul C.","family":"Chitalia","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston University School of Medicine, Boston, MA;"},{"name":"Veterans Affairs Boston Healthcare System, Boston, MA; and"},{"name":"Global Co-Creation Labs, Institute of Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"13","key":"2019122611531876000_B1","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1182\/blood-2017-03-743211","article-title":"Cancer-associated pathways and biomarkers of venous thrombosis","volume":"130","author":"Hisada","year":"2017","journal-title":"Blood"},{"issue":"11","key":"2019122611531876000_B2","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1001\/archinte.162.11.1245","article-title":"Relative impact of risk factors for deep vein thrombosis and pulmonary embolism: a population-based study","volume":"162","author":"Heit","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"2019122611531876000_B3","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1538-7836.2006.01804.x","article-title":"Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study","volume":"4","author":"Blom","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"10","key":"2019122611531876000_B4","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/cncr.23062","article-title":"Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients","volume":"110","author":"Khorana","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"2019122611531876000_B5","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2005.06.058","article-title":"Incidence of venous thromboembolism in patients hospitalized with cancer","volume":"119","author":"Stein","year":"2006","journal-title":"Am J Med"},{"issue":"5","key":"2019122611531876000_B6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"2019122611531876000_B7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"suppl 2","key":"2019122611531876000_B8","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/S0049-3848(07)70128-7","article-title":"Targeting patients for anticoagulant prophylaxis trials in patients with cancer: who is at highest risk?","volume":"120","author":"White","year":"2007","journal-title":"Thromb Res"},{"issue":"1","key":"2019122611531876000_B9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12943-015-0418-x","article-title":"Bevacizumab promotes venous thromboembolism through the induction of PAI-1 in a mouse xenograft model of human lung carcinoma","volume":"14","author":"Chen","year":"2015","journal-title":"Mol Cancer"},{"issue":"3","key":"2019122611531876000_B10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/CIRCULATIONAHA.112.118174","article-title":"Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor","volume":"127","author":"Chitalia","year":"2013","journal-title":"Circulation"},{"issue":"417","key":"2019122611531876000_B11","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam8475","article-title":"Targeting STUB1-tissue factor axis normalizes hyperthrombotic uremic phenotype without increasing bleeding risk","volume":"9","author":"Shashar","year":"2017","journal-title":"Sci Transl Med"},{"issue":"4","key":"2019122611531876000_B12","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/ki.2013.133","article-title":"Indolic uremic solutes increase tissue factor production in endothelial cells by the aryl hydrocarbon receptor pathway","volume":"84","author":"Gondouin","year":"2013","journal-title":"Kidney Int"},{"issue":"3","key":"2019122611531876000_B13","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1681\/ASN.2017080929","article-title":"Uremic solute-aryl hydrocarbon receptor-tissue factor axis associates with thrombosis after vascular injury in humans","volume":"29","author":"Kolachalama","year":"2018","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"2019122611531876000_B14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/sdi.12255","article-title":"Thrombosis in the uremic milieu\u2014emerging role of \u201cthrombolome\u201d","volume":"28","author":"Shashar","year":"2015","journal-title":"Semin Dial"},{"issue":"1","key":"2019122611531876000_B15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1681\/ASN.2014121241","article-title":"The Aryl hydrocarbon receptor is a critical regulator of tissue factor stability and an antithrombotic target in uremia","volume":"27","author":"Shivanna","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"2019122611531876000_B16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s00204-002-0354-6","article-title":"2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines","volume":"76","author":"Son","year":"2002","journal-title":"Arch Toxicol"},{"issue":"9","key":"2019122611531876000_B17","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1515\/BC.2006.150","article-title":"Identifying target genes of the aryl hydrocarbon receptor nuclear translocator (Arnt) using DNA microarray analysis","volume":"387","author":"Wang","year":"2006","journal-title":"Biol Chem"},{"issue":"12","key":"2019122611531876000_B18","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/nrc3846","article-title":"Aryl hydrocarbon receptor ligands in cancer: friend and foe","volume":"14","author":"Murray","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019122611531876000_B19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.lungcan.2009.05.001","article-title":"Increased serum kynurenine\/tryptophan ratio correlates with disease progression in lung cancer","volume":"67","author":"Suzuki","year":"2010","journal-title":"Lung Cancer"},{"issue":"12","key":"2019122611531876000_B20","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.jocn.2015.06.018","article-title":"The kynurenine to tryptophan ratio as a prognostic tool for glioblastoma patients enrolling in immunotherapy","volume":"22","author":"Zhai","year":"2015","journal-title":"J Clin Neurosci"},{"issue":"7","key":"2019122611531876000_B21","first-page":"1320","article-title":"Serum tryptophan and kynurenine concentrations as parameters for indoleamine 2,3-dioxygenase activity in patients with endometrial, ovarian, and vulvar cancer","volume":"21","author":"de Jong","year":"2011","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"2019122611531876000_B22","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.bjc.6603552","article-title":"Tissue factor expression as a possible determinant of thromboembolism in ovarian cancer","volume":"96","author":"Uno","year":"2007","journal-title":"Br J Cancer"},{"issue":"4","key":"2019122611531876000_B23","doi-asserted-by":"crossref","first-page":"e0122046","DOI":"10.1371\/journal.pone.0122046","article-title":"Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers","volume":"10","author":"Puccetti","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"2019122611531876000_B24","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3748\/wjg.v21.i12.3636","article-title":"Helicobacter pylori and serum kynurenine-tryptophan ratio in patients with colorectal cancer","volume":"21","author":"Engin","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"1-6","key":"2019122611531876000_B25","first-page":"117","article-title":"Studies on tryptophan metabolism in Danish bladder cancer patients","volume":"29","author":"Wolf","year":"1975","journal-title":"Acta Vitaminol Enzymol"},{"issue":"2","key":"2019122611531876000_B26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/em.20588","article-title":"Possible roles of excess tryptophan metabolites in cancer","volume":"52","author":"Chung","year":"2011","journal-title":"Environ Mol Mutagen"},{"issue":"4","key":"2019122611531876000_B27","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/cas.13171","article-title":"Predictive and prognostic role of serum neopterin and tryptophan breakdown in prostate cancer","volume":"108","author":"Pichler","year":"2017","journal-title":"Cancer Sci"},{"issue":"44","key":"2019122611531876000_B28","doi-asserted-by":"crossref","first-page":"71136","DOI":"10.18632\/oncotarget.12107","article-title":"c-Cbl mediates the degradation of tumorigenic nuclear \u03b2-catenin contributing to the heterogeneity in Wnt activity in colorectal tumors","volume":"7","author":"Shashar","year":"2016","journal-title":"Oncotarget"},{"issue":"23","key":"2019122611531876000_B29","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.1182\/blood-2012-01-402156","article-title":"Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"issue":"suppl 1","key":"2019122611531876000_B30","first-page":"20227","article-title":"Impact of solid tumors on venous thrombosis: a novel unified model to understand cancer-associated thrombosis","volume":"134","author":"Hiles","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"2019122611531876000_B31","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/ATVBAHA.111.244608","article-title":"Critical review of mouse models of venous thrombosis","volume":"32","author":"Diaz","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"2019122611531876000_B32","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.14440\/jbm.2017.182","article-title":"A mass spectrometric method for quantification of tryptophan-derived uremic solutes in human serum","volume":"4","author":"Zhang","year":"2017","journal-title":"J Biol Methods"},{"issue":"3","key":"2019122611531876000_B33","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1182\/blood-2012-04-424143","article-title":"Tissue factor promotes activation of coagulation and inflammation in a mouse model of sickle cell disease","volume":"120","author":"Chantrathammachart","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2019122611531876000_B34","doi-asserted-by":"crossref","first-page":"G840","DOI":"10.1152\/ajpgi.90639.2008","article-title":"Tissue factor-dependent coagulation contributes to alpha-naphthylisothiocyanate-induced cholestatic liver injury in mice","volume":"296","author":"Luyendyk","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"4","key":"2019122611531876000_B35","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/aje\/kwv242","article-title":"Plasma biomarkers of inflammation, the kynurenine pathway, and risks of all-cause, cancer, and cardiovascular disease mortality: the Hordaland Health Study","volume":"183","author":"Zuo","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"7181","key":"2019122611531876000_B36","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/nature06797","article-title":"Triggers, targets and treatments for thrombosis","volume":"451","author":"Mackman","year":"2008","journal-title":"Nature"},{"issue":"1","key":"2019122611531876000_B37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2004-06-2225","article-title":"Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall","volume":"105","author":"Day","year":"2005","journal-title":"Blood"},{"issue":"7-8","key":"2019122611531876000_B38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3109\/00365521.2011.579159","article-title":"Kynurenic acid synthesis and kynurenine aminotransferases expression in colon derived normal and cancer cells","volume":"46","author":"Walczak","year":"2011","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"2019122611531876000_B39","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1248\/bpb.b18-00171","article-title":"Celastrol suppresses tryptophan catabolism in human colon cancer cells as revealed by metabolic profiling and targeted metabolite analysis","volume":"41","author":"Qi","year":"2018","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"2019122611531876000_B40","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.3390\/metabo8030040","article-title":"Stable isotope-resolved metabolomics shows metabolic resistance to anti-cancer selenite in 3D spheroids versus 2D cell cultures","volume":"8","author":"Fan","year":"2018","journal-title":"Metabolites"},{"issue":"1","key":"2019122611531876000_B41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1242\/jcs.188102","article-title":"Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses","volume":"130","author":"Riedl","year":"2017","journal-title":"J Cell Sci"},{"issue":"5","key":"2019122611531876000_B42","doi-asserted-by":"crossref","first-page":"e0126807","DOI":"10.1371\/journal.pone.0126807","article-title":"Tumor grafting induces changes of gut microbiota in athymic nude mice in the presence and absence of medicinal Gynostemma saponins","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"issue":"1","key":"2019122611531876000_B43","doi-asserted-by":"crossref","first-page":"e16393","DOI":"10.1371\/journal.pone.0016393","article-title":"Microbial dysbiosis in colorectal cancer (CRC) patients","volume":"6","author":"Sobhani","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"2019122611531876000_B44","doi-asserted-by":"crossref","first-page":"e00692","DOI":"10.1128\/mBio.00692-13","article-title":"The gut microbiome modulates colon tumorigenesis","volume":"4","author":"Zackular","year":"2013","journal-title":"MBio"},{"issue":"suppl 2","key":"2019122611531876000_B45","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/S0049-3848(14)50006-0","article-title":"Risk stratification strategies for cancer-associated thrombosis: an update","volume":"133","author":"Khorana","year":"2014","journal-title":"Thromb Res"},{"issue":"1","key":"2019122611531876000_B46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1073\/pnas.1808950116","article-title":"Spatially resolved metabolomics to discover tumor-associated metabolic alterations","volume":"116","author":"Sun","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"2019122611531876000_B47","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","article-title":"Understanding the Intersections between Metabolism and Cancer Biology","volume":"168","author":"Vander Heiden","year":"2017","journal-title":"Cell"},{"issue":"2","key":"2019122611531876000_B48","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcmd.2005.12.018","article-title":"Cancer-associated thrombosis","volume":"36","author":"Furie","year":"2006","journal-title":"Blood Cells Mol Dis"},{"issue":"19","key":"2019122611531876000_B49","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1182\/blood-2016-10-744060","article-title":"Indoxyl sulfate induces platelet hyperactivity and contributes to chronic kidney disease-associated thrombosis in mice","volume":"129","author":"Yang","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2019122611531876000_B50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.blre.2014.03.003","article-title":"Aspirin for prevention and treatment of venous thromboembolism","volume":"28","author":"Becattini","year":"2014","journal-title":"Blood Rev"},{"issue":"5","key":"2019122611531876000_B51","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/CIRCULATIONAHA.105.567297","article-title":"Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"113","author":"Steffel","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"2019122611531876000_B52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/138920011795016827","article-title":"Interactions of the aryl hydrocarbon receptor with inflammatory mediators: beyond CYP1A regulation","volume":"12","author":"Vondr\u00e1cek","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"3-4","key":"2019122611531876000_B53","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1159\/000175156","article-title":"The plasminogen activator system and cancer","volume":"36","author":"McMahon","year":"2008","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"15","key":"2019122611531876000_B54","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-15-0876","article-title":"Plasminogen activator inhibitor-1 in cancer: rationale and insight for future therapeutic testing","volume":"75","author":"Placencio","year":"2015","journal-title":"Cancer Res"},{"issue":"17","key":"2019122611531876000_B55","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J Clin Oncol"},{"issue":"24","key":"2019122611531876000_B56","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"issue":"suppl 1","key":"2019122611531876000_B57","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1016\/S0049-3848(16)30136-0","article-title":"PO-03\u2014Khorana score and histotype predict the incidence of early venous thromboembolism (VTE) in Non Hodgkin Lymphoma (NHL). A pooled data analysis of twelve clinical trials of Fondazione Italiana Linfomi (FIL)","volume":"140","author":"Santi","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"2019122611531876000_B58","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1111\/jth.13594","article-title":"Predictors of active cancer thromboembolic outcomes: validation of the Khorana score among patients with lung cancer: comment","volume":"15","author":"Noble","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2019122611531876000_B59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2174\/138920011795016818","article-title":"Endogenous and exogenous ligands of aryl hydrocarbon receptor: current state of art","volume":"12","author":"Stejskalova","year":"2011","journal-title":"Curr Drug Metab"},{"issue":"13","key":"2019122611531876000_B60","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1182\/blood-2018-08-868067","article-title":"Neutrophils, NETs, and immunothrombosis","volume":"132","author":"Grover","year":"2018","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2399\/1549689\/bloodbld2019001675.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2399\/1549689\/bloodbld2019001675.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T07:55:38Z","timestamp":1611734138000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/26\/2399\/422726\/Metabolites-in-a-mouse-cancer-model-enhance-venous"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":60,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019001675","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}